Granules India Limited (GRANULES:NSE) Stock Forecast
Alert
Its only available to paid users.
INR 489.75
(+17.14%)
Based on the Granules India Limited stock forecast from 4 analysts, the average analyst target price for Granules India Limited is INR 489.75 over the next 12 months. Granules India Limited’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Granules India Limited is Bullish , which is based on 6 positive signals and 2 negative signals. At the last closing, Granules India Limited’s stock price was INR 418.10. Granules India Limited’s stock price has changed by +0.57% over the past week, -2.94% over the past month and +40.54% over the last year.
No recent analyst target price found for Granules India Limited
No recent average analyst rating found for Granules India Limited
Company Overview Granules India Limited
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India. Read Less
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various...Read More
Frequently Asked Questions About Granules India Limited (GRANULES:NSE) Stock
Based on ratings from 4 analysts Granules India Limited's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bullish . The stock has 4 buy, sell and hold ratings.
GRANULES:NSE stock's dividend yield is 0.35%.
Our analysis grades GRANULES:NSE stock's dividend yield at F. This means that GRANULES:NSE stock's dividend yield is above 33% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange.
Based on this GRANULES:NSE may be a poor dividend stock for its sector.
Based on targets from 4 analysts, the average taret price for GRANULES:NSE is INR 489.75 over the next 12 months. The maximum analyst target price is INR 515 while the minimum anlayst target price is INR 464.
GRANULES:NSE stock's Price/Earning ratio is 26.39.
Our analysis grades GRANULES:NSE stock's Price / Earning ratio at D+. This means that GRANULES:NSE stock's Price/Earning ratio is above 32% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSE exchange.
Based on this GRANULES:NSE may be fairly valued for its sector
The last closing price of GRANULES:NSE's stock was INR 418.10.
The most recent market capitalization for GRANULES:NSE is INR 104.26B.
Based on targets from 4 analysts, the average taret price for GRANULES:NSE is projected at INR 489.75 over the next 12 months.
This means that GRANULES:NSE's stock price may go up by +17.14% over the next 12 months.
We can't find any ETFs which contains Granules India Limited's stock.
As per our most recent records Granules India Limited has 3,650 Employees.
Granules India Limited's registered address is My Home Hub, Hyderabad, India, 500081.
You can get more information about it from Granules India Limited's website at https://www.granulesindia.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GRANULES:NSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
